Idexx Laboratories IDXX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $278.45M+14.7% | $248.19M+14.8% | $274.61M+17.9% | $293.99M+44.6% | $242.68M+3.0% | ||
| $37.68M+10.6% | $38.72M+14.9% | $36.63M+7.3% | $35.77M+11.1% | $34.06M+13.9% | ||
| $16.34M+11.8% | $16.11M+13.0% | $14.43M-9.3% | $14.85M-5.5% | $14.62M+1.5% | ||
| $13.89M+252% | $31.53M— | $93.25M+1,461% | $2.48M+113% | $3.95M+254% | ||
| $5M— | —— | $0— | $0— | $0-100% | ||
| $3.94M+36.4% | $2.45M+37.1% | $1.62M+21.1% | $1.47M-33.6% | $2.89M+88.9% | ||
| $56.81M+25.6% | —— | $7.7M— | $29.65M+1.7% | $45.24M-16.0% | ||
| -$2.24M-3.5% | —— | —— | $6.24M+64.3% | -$2.16M-190% | ||
| $11.22M+238% | -$3.6M-163% | —— | -$3.99M-148% | -$8.12M-82.5% | ||
| $695K+52.4% | $1.78M+311% | $1.75M+2,516% | $1.04M+1,684% | $456K-49.8% | ||
| $266.25M+11.9% | $355.76M+35.8% | $402.34M+82.8% | $185.74M-25.2% | $237.96M+19.8% | ||
| $31.98M+6.5% | $29.43M+0.6% | $31.11M+10.8% | $34.1M+2.4% | $30.03M-0.8% | ||
| $1.8M— | $200K-98.0% | —— | —— | $0— | ||
| $799K— | —— | —— | —— | $0— | ||
| -$33.54M-13.3% | -$28.13M+29.4% | -$44.87M-64.0% | -$33.63M-2.2% | -$29.61M+72.3% | ||
| $351.04M-12.4% | $237.77M-3.3% | $240.2M+8.8% | $338.11M+56.9% | $400.89M+159% | ||
| $18.16M+152% | $17.87M+34.8% | $50.97M+920% | $17.33M+223% | $7.19M-65.5% | ||
| $10.56M+72.4% | $60K+33.3% | $85K-61.0% | $970K+1,128% | $6.12M-39.9% | ||
| -$211.43M+36.0% | -$355.7M-52.8% | -$313.31M-7.7% | -$165.63M+21.2% | -$330.32M-129% | ||
| -$816K+64.9% | —— | —— | $14.14M+1,500% | -$2.33M+42.8% | ||
| $20.46M+116% | -$28.1M-37.9% | —— | —— | -$124.3M-120% | ||
| $5M— | —— | $0— | $0— | $0-100% | ||
| $3.94M+36.4% | $2.45M+37.1% | $1.62M+21.1% | $1.47M-33.6% | $2.89M+88.9% | ||
| $799K— | —— | —— | —— | $0— | ||
| $1.8M— | $200K-98.0% | —— | —— | $0— | ||
| $18.16M+152% | $17.87M+34.8% | $50.97M+920% | $17.33M+223% | $7.19M-65.5% | ||
| $132M+89.9% | —— | —— | $259.5M— | $69.5M— | ||
| —— | $62.5M— | $62.5M— | $62.5M— | $62.5M— | ||
| $8.27M-22.7% | —— | —— | —— | $10.7M-29.5% | ||
| $1.04M+150% | $1.5M+262% | $349K-15.9% | $474K+19.1% | $416K+26.4% | ||
| —— | $62.5M— | $62.5M— | $62.5M— | $62.5M— | ||
| $234.26M+12.7% | $326.33M+40.2% | $371.23M+93.4% | $151.64M-29.5% | $207.94M+23.5% | ||
| $234.26M+12.7% | $326.33M+40.2% | $371.23M+93.4% | $151.64M-29.5% | $207.94M+23.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Idexx Laboratories generate?
- Idexx Laboratories (IDXX) generated $1.2B in operating cash flow over the trailing twelve months.
- What is Idexx Laboratories's free cash flow?
- After $126.6M of capital expenditures, Idexx Laboratories's free cash flow was $1.1B over the trailing twelve months, up 27.8% year over year.
- Where does Idexx Laboratories's cash flow data come from?
- Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
